Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Blood (2018) 131 (23): 2541–2551.

https://doi.org/10.1182/blood-2017-11-814608

Published: 2018

Includes: Supplemental data

Journal Articles

A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1

Kristin A Rand, Ph.D., M.P.H., Nicola Camp, PhD, Alessandro Martino, Ph.D., Eric W. Dean, MD, Daniel J. Serie, Ph.D., Christopher K. Edlund, M.S., Donglei Hu, M.S., Karen Curtin, Ph.D., Scott Huntsman, MS, David J. Van Den Berg, Ph.D., Anneclaire De Roos, PhD, Elizabeth E Brown, Ph.D., Graham G. Giles, Ph.D., John J. Spinelli, Ph.D., Sikander Ailawadhi, M.D., Brenda M. Birmann, ScD, Angela R Brooks-Wilson, Ph.D., Richard K Severson, PhD, Paige M Bracci, PhD, Mulugeta Gebregziabher, PhD, Michael H. Tomasson, MD, Ann M. Mohrbacher, MD, Guido J. Tricot, M.D., Ph.D., Daniele Campa, M.D., Ph.D., Thomas Martin, III, M.D., Brian E. Henderson, M.D., Maurizio Zangari, MD, Nathaniel Rothman, MD, MPH, MHS, Stephen Jacob Chanock, MD, Shaji Kumar, MD, Laurence N. Kolonel, MD, PhD, Jeffrey Lee Wolf, MD, Graham A Colditz, M.D., Dr.PH., S. Vincent Rajkumar, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Christopher Haiman, Sc.D., David V. Conti, Ph.D., Federico Canzian, PhD, Celine M Vachon, PhD, Elad Ziv, MD, Wendy Cozen, D.O., M.P.H.

Blood (2013) 122 (21): 3111.

https://doi.org/10.1182/blood.V122.21.3111.3111

Published: 2013

Journal Articles

Polymorphisms In IRS1 and IL6R and Susceptibility To Multiple Myeloma

Blood (2013) 122 (21): 3154.

https://doi.org/10.1182/blood.V122.21.3154.3154

Published: 2013

Journal Articles

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium

Blood (2012) 120 (23): 4645–4648.

https://doi.org/10.1182/blood-2012-05-427989

Published: 2012

Includes: Supplemental data

Journal Articles

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology

Sophia S. Wang, Amr M. Abdou, Lindsay M. Morton, Rasmi Thomas, James R. Cerhan, Xiaojiang Gao, Wendy Cozen, Nathaniel Rothman, Scott Davis, Richard K. Severson, Leslie Bernstein, Patricia Hartge, Mary Carrington

Blood (2010) 115 (23): 4820–4823.

https://doi.org/10.1182/blood-2010-01-266775

Published: 2010

Includes: Supplemental data

Journal Articles

Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma

Joanne S. Colt, Nathaniel Rothman, Richard K. Severson, Patricia Hartge, James R. Cerhan, Nilanjan Chatterjee, Wendy Cozen, Lindsay M. Morton, Anneclaire J. De Roos, Scott Davis, Stephen Chanock, Sophia S. Wang

Blood (2009) 113 (9): 1899–1905.

https://doi.org/10.1182/blood-2008-04-153858

Published: 2009

Includes: Supplemental data

Journal Articles

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes

Blood (2008) 112 (13): 5150–5160.

https://doi.org/10.1182/blood-2008-01-133587

Published: 2008

Includes: Supplemental data

Journal Articles

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era

Thomas M. Habermann, Sophia S. Wang, Matthew J. Maurer, Lindsay M. Morton, Charles F. Lynch, Stephen M. Ansell, Patricia Hartge, Richard K. Severson, Nathaniel Rothman, Scott Davis, Susan M. Geyer, Wendy Cozen, Stephen J. Chanock, James R. Cerhan

Blood (2008) 112 (7): 2694–2702.

https://doi.org/10.1182/blood-2007-09-111658

Published: 2008

Includes: Supplemental data

Journal Articles

Polymorphisms in One-Carbon Metabolism Genes and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL).

James R. Cerhan, MD, PhD, Matthew J. Maurer, MS, Patricia Hartge, PhD, Stephen J. Chanock, MD, Thomas M. Habermann, MD, Wendy Cozen, MD, Scott Davis, PhD, Charles F. Lynch, MD, PhD, Richard K. Severson, PhD, Nathaniel Rothman, MD, Lindsay M. Morton, PhD, Sophia S. Wang, PhD

Blood (2007) 110 (11): 1568.

https://doi.org/10.1182/blood.V110.11.1568.1568

Published: 2007

Journal Articles

Host Genetic Variation in the Cell Cycle and NF-κB Pathways and Overall Survival in Mantle Cell Lymphoma.

Thomas M. Habermann, MD, Matthew J. Maurer, MS, Sophia S. Wang, PhD, Lindsay M. Morton, PhD, Charles F. Lynch, MD, PhD, Patricia Hartge, PhD, Wendy Cozen, MD, Richard K. Severson, PhD, Davis Scott, PhD, David A. Watson, MS, Stephen J. Chanock, MD, Nathanial Rothman, MD, James R. Cerhan, MD, PhD

Blood (2007) 110 (11): 1582.

https://doi.org/10.1182/blood.V110.11.1582.1582

Published: 2007

Journal Articles

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival

James R. Cerhan, Sophia Wang, Matthew J. Maurer, Stephen M. Ansell, Susan M. Geyer, Wendy Cozen, Lindsay M. Morton, Scott Davis, Richard K. Severson, Nathaniel Rothman, Charles F. Lynch, Sholom Wacholder, Stephen J. Chanock, Thomas M. Habermann, Patricia Hartge

Blood (2007) 109 (12): 5439–5446.

https://doi.org/10.1182/blood-2006-11-058040

Published: 2007

Includes: Supplemental data

Journal Articles

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)

Blood (2006) 109 (8): 3479–3488.

https://doi.org/10.1182/blood-2006-06-031948

Published: 2006

Journal Articles

Childhood Crowding, Atopy and Risk of Non-Hodgkin Lymphoma.

Wendy Cozen, DO, MPH, Engels A. Eric, M.D., M.P.H., James R. Cerhan, M.D., Ph.D., Martha Linet, M.D., M.P.H., Leslie Bernstein, Ph.D., Joanne S. Colt, M.P.H., M.S., Scott S. Davis, Ph.D., M.S., Richard K. Severson, Ph.D., Otoniel Martinez-Maza, Ph.D., Patricia Hartge, Sc.D.

Blood (2006) 108 (11): 4648.

https://doi.org/10.1182/blood.V108.11.4648.4648

Published: 2006

Journal Articles

Smoking, Obesity and Overall Survival in Non-Hodgkin Lymphoma (NHL): A Population-Based Study.

Susan M. Geyer, PhD, Lindsay M. Morton, PhD, Thomas M. Habermann, MD, Cristine Allmer, Scott Davis, PhD, Wendy Cozen, MD, Richard K. Severson, PhD, Charles F. Lynch, MD,PhD, Sophia Wang, PhD, Matthew J. Maurer, MS, Patricia Hartge, PhD, James R. Cerhan, MD, PhD

Blood (2006) 108 (11): 4649.

https://doi.org/10.1182/blood.V108.11.4649.4649

Published: 2006

Journal Articles

Cytokine Gene Polymorphisms and Overall Survival in Follicular Lymphoma: Results from a Large Population-Based Study.

James R. Cerhan, MD, PhD, Sophia Wang, PhD, Matthew J. Maurer, MS, Stephen M. Ansell, MD, PhD, Susan M. Geyer, PhD, Wendy Cozen, MD, Lindsay M. Morton, PhD, Scott Davis, PhD, Richard K. Severson, PhD, Nathaniel Rothman, MD, Charles F. Lynch, MD, PhD, Stephen Chanock, MD, Thomas M. Habermann, MD, Patricia Hartge, PhD

Blood (2006) 108 (11): 820.

https://doi.org/10.1182/blood.V108.11.820.820

Published: 2006

Journal Articles

Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes

Deirdre A. Hill, Sophia S. Wang, James R. Cerhan, Scott Davis, Wendy Cozen, Richard K. Severson, Patricia Hartge, Sholom Wacholder, Meredith Yeager, Stephen J. Chanock, Nathaniel Rothman

Blood (2006) 108 (9): 3161–3167.

https://doi.org/10.1182/blood-2005-01-026690

Published: 2006

Includes: Supplemental data

Journal Articles

Host Immunogenetic Single Nucleotide Polymorphisms (SNPs) Predict Overall Survival in Small Lymphocytic Lymphoma.

Carrie A. Thompson, MD, Sophia Wang, PhD, Matthew J. Maurer, MS, Thomas M. Habermann, MD, Richard K. Severson, PhD, Nathaniel Rothman, MD, Charles F. Lynch, MD, PhD, Scott Davis, PhD, Lindsay M. Morton, PhD, Wendy Cozen, MD, Patricia Hartge, PhD, Susan M. Geyer, PhD, Stephen Chanock, MD, James R. Cerhan, MD, PhD

Blood (2006) 108 (11): 2396.

https://doi.org/10.1182/blood.V108.11.2396.2396

Published: 2006

Journal Articles

Germline Single Nucleotide Polymorphisms (SNPs) in IL1A , IL6 , IL10 , and IFNGR2 in Combination with Clinical with Demographic Factors Predict Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL).

Thomas M. Habermann, MD, Sophia Wang, PhD, Matthew J. Maurer, Lindsay M. Morton, PhD, Charles F. Lynch, MD, PhD, Stephen M. Ansell, MD, PhD, Patricia Hartge, PhD, Richard K. Severson, PhD, Nathaniel Rothman, MD, Scott Davis, PhD, Susan M. Geyer, PhD, Wendy Cozen, MD, Stephen Chanock, MD, James R. Cerhan

Blood (2006) 108 (11): 2028.

https://doi.org/10.1182/blood.V108.11.2028.2028

Published: 2006

Journal Articles

Blood Transfusion, Anesthesia, Surgery and Risk of Non-Hodgkin Lymphoma.

James R. Cerhan, MD, PhD, Eric Engels, MD, Wendy Cozen, MD, Scott Davis, PhD, Richard K. Severson, PhD, Gloria Gridley, MS, Patricia Hartge, ScD, Martha Linet, MD

Blood (2005) 106 (11): 4697.

https://doi.org/10.1182/blood.V106.11.4697.4697

Published: 2005

NARROW

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1

Polymorphisms In IRS1 and IL6R and Susceptibility To Multiple Myeloma

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology

Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era

Polymorphisms in One-Carbon Metabolism Genes and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL).

Host Genetic Variation in the Cell Cycle and NF-κB Pathways and Overall Survival in Mantle Cell Lymphoma.

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)

Childhood Crowding, Atopy and Risk of Non-Hodgkin Lymphoma.

Smoking, Obesity and Overall Survival in Non-Hodgkin Lymphoma (NHL): A Population-Based Study.

Cytokine Gene Polymorphisms and Overall Survival in Follicular Lymphoma: Results from a Large Population-Based Study.

Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes

Host Immunogenetic Single Nucleotide Polymorphisms (SNPs) Predict Overall Survival in Small Lymphocytic Lymphoma.

Germline Single Nucleotide Polymorphisms (SNPs) in IL1A , IL6 , IL10 , and IFNGR2 in Combination with Clinical with Demographic Factors Predict Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL).

Blood Transfusion, Anesthesia, Surgery and Risk of Non-Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only